Who owns AADI BIOSCIENCE INC COM?
- Ticker: AADI
- CUSIP Number: 00032q104
Tip: Access positions for across all investors
Analyze quarterly positions in Aadi Bioscience with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aadi Bioscience stock
Who bought or sold AADI BIOSCIENCE INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BML Capital Management | 2.0M | $4.1M | 100% | Sep 2024 |
|
| Vanguard Group | 766k | $1.1M | -11% | Jun 2024 |
|
| Renaissance Technologies | 462k | $951k | 5% | Sep 2024 |
|
| Acuitas Investments | 439k | $904k | 24% | Sep 2024 |
|
| Soleus Capital Management | 333k | $487k | 100% | Jun 2024 |
|
| BlackRock | 320k | $468k | -69% | Jun 2024 |
|
| BlackRock | 243k | $500k | 100% | Sep 2024 |
|
| Geode Capital Management | 209k | $430k | 1% | Sep 2024 |
|
| Goldman Sachs Group | 154k | $225k | 211% | Jun 2024 |
|
| Verition Fund Management | 82k | $120k | 156% | Jun 2024 |
|
| Susquehanna International | 72k | $148k | -28% | Sep 2024 |
|
| State Street Corporation | 69k | $100k | -82% | Jun 2024 |
|
| Northern Trust | 69k | $141k | -57% | Sep 2024 |
|
| Morgan Stanley | 65k | $95k | -86% | Jun 2024 |
|
| Marquette Asset Management | 64k | $131k | 0% | Sep 2024 |
|
| Affinity Asset Advisors | 47k | $97k | 100% | Sep 2024 |
|
| Schonfeld Strategic Advisors | 42k | $86k | 0% | Sep 2024 |
|
| Dimensional Fund Advisors | 36k | $73k | 0% | Sep 2024 |
|
| Citadel Advisors | 31k | $64k | -94% | Sep 2024 |
|
| Jane Street | 26k | $54k | -81% | Sep 2024 |
|
| GSA Capital Partners | 21k | $43k | -23% | Sep 2024 |
|
| Squarepoint Ops | 21k | $30k | 100% | Jun 2024 |
|
| Two Sigma Advisers | 15k | $22k | 100% | Jun 2024 |
|
| Man Group | 15k | $30k | 100% | Sep 2024 |
|
| Tower Research Capital | 14k | $20k | 291% | Jun 2024 |
|
| Point72 Asia | 12k | $25k | -52% | Sep 2024 |
|
| Qube Research & Technologies | 12k | $18k | 100% | Jun 2024 |
|
| Federated Investors | 4.8k | $9.9k | 12% | Sep 2024 |
|
| Jpmorgan Chase & Co | 4.2k | $8.7k | 906% | Sep 2024 |
|
| Us Bancorp | 3.3k | $6.9k | 0% | Sep 2024 |
|
| Wells Fargo & Company | 2.8k | $5.8k | -7% | Sep 2024 |
|
| Simplex Trading | 2.3k | $4.0k | -6% | Sep 2024 |
|
| Advisor Group Holdings | 1.4k | $3.0k | 628% | Sep 2024 |
|
| Bartlett & Co. Wealth Management | 1.3k | $2.7k | 0% | Sep 2024 |
|
| Cubist Systematic Strategies | 1.0k | $2.1k | -79% | Sep 2024 |
|
| Macquarie Group | 830.00 | $1.2k | 100% | Jun 2024 |
|
| Satter Management | 659.00 | $1.4k | -100% | Sep 2024 |
|
| TD Waterhouse Canada | 232.00 | $454.998400 | 0% | Sep 2024 |
|
| Bank of America Corporation | 213.00 | $438.375300 | -93% | Sep 2024 |
|
| Citigroup | 81.00 | $166.997700 | -97% | Sep 2024 |
|
| Point72 | 77.00 | $158.997300 | -98% | Sep 2024 |
|
| CWM | 25.00 | $0 | -84% | Sep 2024 |
|
| Parallel Advisors | 8.00 | $16.000000 | 0% | Sep 2024 |
|
Who sold out of Aadi Bioscience?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2024 | 226k | $330k |
| 683 Capital Management | Jun 2024 | 80k | $117k |
| Y-Intercept | Jun 2024 | 49k | $72k |
| Centiva Capital | Jun 2024 | 33k | $48k |
| Hrt Financial | Jun 2024 | 28k | $41k |
| Virtu Financial | Jun 2024 | 28k | $40k |
| Nuveen Asset Management | Mar 2024 | 21k | $49k |
| Sunrise Partners Limited Partnership | Jun 2024 | 19k | $28k |
| D. E. Shaw & Co | Jun 2024 | 18k | $26k |
| Rhumbline Advisers | Jun 2024 | 9.5k | $14k |
| Mirae Asset Global Etfs Holdings | Jun 2024 | 8.1k | $12k |
| Russell Investments | Mar 2024 | 970.00 | $2.3k |
| Ohio Pers | Jun 2024 | 943.00 | $1.4k |
| Royal Bank of Canada | Jun 2024 | 917.00 | $999.988500 |
| Pnc Financial Services | Jun 2024 | 368.00 | $536.985600 |
| Private Wealth Management Group | Mar 2024 | 285.00 | $667.014000 |
| New York State Common Retirement Fund | Jun 2024 | 141.00 | $0 |
| NISA Investment Advisors | Jun 2024 | 131.00 | $190.998000 |
| Farther Finance Advisors | Jun 2024 | 54.00 | $76.998600 |
| Barclays | Jun 2024 | 8.00 | $0 |